10x Genomics, Inc.
TXG · XNASCIK 1770787fmd_1WSV4C8VC7WAX8N46RPNVX8AYCManufacturing · Laboratory Analytical InstrumentsTemplate: Standard
Coverage: Jan 01, 2017 to Sep 30, 2026, 36 periods
| Line item | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 71 | 146 | 246 | 299 | 490 | 516 | 619 | 611 | 643 |
| Cost of revenue | 11 | 29 | 61 | 58 | 74 | 120 | 209 | 196 | 199 |
| Gross profit | 61 | 118 | 185 | 240 | 416 | 396 | 409 | 414 | 444 |
| Research and development | 32 | 48 | 83 | 123 | 212 | 266 | 270 | 265 | 239 |
| Selling, general and administrative | 47 | 88 | 131 | 202 | 258 | 298 | 343 | 344 | 316 |
| Total operating expenses | 79 | 228 | 215 | 775 | 469 | 564 | 675 | 609 | 505 |
| Operating income | (18) | (111) | (31) | (534) | (52) | (168) | (265) | (195) | (61) |
| Interest expense | 1 | 2 | 3 | 2 | 1 | 0 | 0 | 0 | 0 |
| Interest and investment income | 0 | 1 | 3 | 2 | 0 | 7 | 17 | 19 | 20 |
| Other non-operating income (expense) | (0) | (2) | (0) | (0) | (1) | 6 | 17 | 17 | 21 |
| Income before taxes | (19) | (112) | (31) | (534) | (54) | (162) | (249) | (178) | (40) |
| Income tax expense | 0 | 0 | 0 | 8 | 5 | 4 | 6 | 5 | 4 |
| Net income from continuing operations | (19) | (112) | (31) | (543) | (58) | (166) | (255) | (183) | (44) |
| Net income | (19) | (112) | (31) | (543) | (58) | (166) | (255) | (183) | (44) |